Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.

about

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.

Item

http://www.wikidata.org/entity/Q35971034

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.

@ast

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.

@en

type

Item

label

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.

@ast

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.

@en

prefLabel

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.

@ast

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.

@en

P1476

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.

@en

P2093

Breanne Terakedis

http://www.w3.org/2001/XMLSchema#string

William Sause

http://www.w3.org/2001/XMLSchema#string

P2860

Noninvasive staging of non-small cell lung cancer: a review of the current evidence.

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lun

A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117

Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

Radiogenomics predicting tumor responses to radiotherapy in lung cancer

Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.

Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemi

The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.

Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2011.00047

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225074816

http://www.w3.org/2001/XMLSchema#string

P698

22645713

http://www.w3.org/2001/XMLSchema#string

P932

3355841

http://www.w3.org/2001/XMLSchema#string